< Back to situations

We’ll email you as it develops, and you can follow the whole thread from day one.

[SITUATION] · [ACTIVE]

2 clusters · 5 sources · 2 days · First seen · Last updated

Categories: BUSINESS

Greek corporate earnings outlook

Entities: Eurobank · Aspropyrgos refinery · National Bank of Greece · Piraeus Bank · Lavipharm

Overview

On 27 July 2026, analyst firm Optima projected a strong quarter for Helleniq Energy, forecasting adjusted EBITDA of €382 million – a 73 % increase year‑on‑year – and an adjusted net profit of €205 million, driven by a favourable refining environment and inventory gains linked to higher oil prices. The same report highlighted Lavipharm’s expected annual sales growth of 25.9 % from 2025‑2030 and a 34.5 % yearly rise in EBITDA, citing new medical‑cannabis products, an OTC antiseptic partnership and upcoming rights acquisitions as profit drivers.

The following day, 28 July 2026, Axia Alpha Finance issued a bullish outlook for Greece’s major banks – Eurobank, National Bank of Greece, Piraeus Bank and Bank of Cyprus – recommending buy ratings and projecting total net profit of €1.43 billion for Q2, with a return on tangible equity of 15.4 %. For the telecom group OTE, the firm expected modest revenue growth to €868.5 million (up 1.6 % YoY) and an adjusted EBITDA of €342.6 million, driven by FTTH expansion, fixed‑wireless rollout, prepaid‑to‑contract migration and growth in TV and ICT services. Together, the two forecasts illustrate a broadly optimistic outlook for key Greek sectors, with strong earnings growth anticipated in energy, pharmaceuticals, banking and telecom throughout 2026.

Timeline

  1. 2 days ago

    [BUSINESS] 3 sources
    Axia Alpha Finance forecasts earnings gains for Greece's top banks and OTE

    Axia Alpha Finance predicts profit growth for Greece's major banks with buy ratings and target prices, and forecasts modest revenue and EBITDA gains for telecom operator OTE driven by FTTH and FWA expansion.

  2. 3 days ago

    [BUSINESS] 2 sources
    Optima projects robust growth for Greece's Helleniq Energy and Lavipharm

    Optima sees Helleniq Energy’s Q2 EBITDA jump 73% to €382 M and Lavipharm’s sales rise 25.9% annually, citing strong refining margins and new product launches.

Sources

insider.gr · marketnews.gr · ot.gr · Reporter.gr · tradeinvestsa.co.za

This summary has been updated 1 time: see revision history